AME vs EMR
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 14, 2026
AME
EMR
Investment Advisor Scores
EMR
AI Analyst Insights
Detailed Metrics Comparison
| Metric | AME | EMR | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 32.5733 | 22.0751 | EMR |
| PEG Ratio | 3.2286 | 1.8318 | EMR |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 15.0% | 7.0% | AME |
| Earnings Growth | 14.2% | 23.0% | EMR |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 38.1/100 | 30.3/100 | AME |
| Profit Margin | 20.0% | 13.8% | AME |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | SELL | SELL | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
AME
NeutralMixed signals - no dominant trend phase, RSI 42
EMR
MarkupPrice above SMA50, rising 50-day trend (5.3% over 20 days), RSI 55
Fundamentals Snapshot
| Metric | AME | EMR |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 26.6 | 21.7 |
| Trailing P/E | 35.6 | 34.5 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.2% | 0.1% |
| Gross Margin | 0.4% | 0.5% |
| Operating Margin | 0.3% | 0.3% |
| EPS | 6.72 | 4.49 |
| Dividend Yield | 0.01% | 0.01% |